AML IP v. Orveon Global: E-Commerce Token Patent Case Settles

Introduction

A patent infringement dispute centered on electronic commerce transaction technology reached a quiet but strategically significant conclusion at the Southern District of New York in 2025. In AML IP, LLC v. Orveon Global US LLC (Case No. 1:25-cv-00970), the parties reached a settlement in principle just 168 days after filing, resulting in a court-ordered discontinuation without prejudice on July 21, 2025.

At the heart of the case was U.S. Patent No. 7,177,838 B1, covering a method and apparatus for conducting electronic commerce transactions using electronic tokens — a foundational technology area that remains commercially relevant across retail, beauty tech, and digital payments sectors. Plaintiff AML IP, LLC, a patent assertion entity, targeted Orveon Global US LLC, the parent company behind prestige beauty brands including bareMinerals, Buxom, and Laura Mercier.

For patent attorneys, IP professionals, and R&D teams operating in e-commerce and digital transaction environments, this case offers timely insights into non-practicing entity (NPE) litigation dynamics, settlement pacing, and freedom-to-operate risk in electronic token patent infringement disputes.

Case Overview

The Parties

The Patent at Issue

This landmark case involved a single U.S. Patent covering a method and apparatus for conducting electronic commerce transactions using electronic tokens, a foundational technology area that remains commercially relevant:

• • US7,177,838 B1 — Method and apparatus for conducting electronic commerce transactions using electronic tokens

Litigation Timeline & Procedural History

Timeline

The case was filed on February 3, 2025, in the U.S. District Court for the Southern District of New York (SDNY) — a venue known for sophisticated IP docket management and experienced federal judges. SDNY’s selection by the plaintiff reflects a common strategic choice among patent assertion entities targeting New York-headquartered or incorporated companies.

The case resolved within 168 days, a notably accelerated timeline relative to the national median for patent infringement cases, which typically range from 18 to 36 months through trial. This rapid closure is characteristic of settlements reached before significant discovery investment or claim construction proceedings, suggesting early-stage negotiation likely commenced shortly after the complaint was served.

The basis of termination was recorded as **dismissed without prejudice**, preserving both parties’ rights within a 30-day restoration window as ordered by the court.

Verdict Cause Analysis

The court issued an order discontinuing the action following notification that the parties reached a settlement in principle. The dismissal was entered without costs to either party and without prejudice, with a 30-day window to restore the action to the docket if settlement terms were not finalized. No damages figure was publicly disclosed, and no injunctive relief was granted or denied on the merits — consistent with a pre-trial commercial resolution.

The speed of settlement is analytically significant. Orveon’s retention of Amster Rothstein & Ebenstein, LLP — a firm with recognized strength in both patent litigation defense and inter partes review (IPR) proceedings — may have signaled to the plaintiff that a robust invalidity or non-infringement defense was forthcoming, creating settlement incentive. Conversely, AML IP may have prioritized a negotiated resolution over the cost and uncertainty of protracted litigation.